InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-29.9%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the full record of transactions filed by Wallar Gina M, Président, Services Pharmaceutiques. Insider active across 1 company, notably Neogenomics INC. In total, 5 reports have been logged. History available since 5 July 2021. The latest transaction was filed on 1 March 2022 (Attribution). Regulator: SEC (Form 4). All data is free.
Declarations5 total
11,677 shares0Common StockSEC:0001077183-22-000038:0
15,286 shares0Common StockSEC:0001077183-21-000280
15,286 shares0Common StockSEC:0001077183-21-000280:0
1,896 shares0Common StockSEC:0001077183-21-000186:0
1,896 shares0Common StockSEC:0001077183-21-000186
5 of 5 declarations
About Wallar Gina M
Gina M. Wallar is the President of Pharma Services at NEOGENOMICS INC. In this role, she oversees the operations and development of the company's pharmaceutical services. Her expertise in the healthcare sector is essential to ensure the quality of the services offered. Gina M. Wallar collaborates with her team to develop initiatives that promote innovation and expansion of services.
